Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blue dye could spare ovarian cancer patients from major lymph node surgery

NCT ID NCT07508306

Recruiting now Knowledge-focused Sponsor: Faculty of Medicine of Tunis Source: ClinicalTrials.gov ↗

First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 7 times

Summary

This study tests whether a blue dye injected into the ovary can help surgeons find the first lymph node that might contain cancer in people with early-stage ovarian cancer. Currently, standard surgery removes many lymph nodes, which can cause side effects. The goal is to see if this dye-guided approach is accurate enough to replace the more extensive lymph node removal. About 30 adults with stage I or II ovarian cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENTINEL LYMPH NODE BIOPSY (SLNB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maternity and neonatology center of Tunis

    RECRUITING

    La Rabta, 1007, Tunisia

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

EARLY STAGE OVARIAN TUMORS SENTINEL LYMPH NODE BIOPSY (SLNB)